Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn.

Source:http://linkedlifedata.com/resource/pubmed/id/9794957

Download in:

View as

General Info

PMID
9794957